No Pharma Money
David Mitchell embraced by President Biden at the White House
News & Reports

The latest from P4ADNow

The latest news, research, policy analysis, and updates from the fight to lower prescription drug prices.

Stay Up To Date

News and reports from P4ADNow

Press Releases Mar 8, 2023

STATEMENT: P4ADNow Urges Members of House Energy and Commerce Subcommittee On Health To Vote Against H.R. 485 As Currently Written

The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now, ahead of the House Energy and Commerce Subcommittee on Health markup on H.R. 485:

Read Article
News Mar 6, 2023

The Week in Review in Prescription Drug Pricing

Too soon: Cherry blossom peak bloom?. Not soon enough: Eli Lilly’s insulin price reduction?.

Read Article
News Feb 25, 2023

The Week in Review in Prescription Drug Pricing

Just like Angela Bassett, the Senate Judiciary Committee did the thing, and passed five bipartisan bills to help fix key elements of our rigged drug price system.

Read Article
News Feb 17, 2023

ICYMI: P4ADNow In The News – Debunking Big Pharma, Fighting For Future Reforms, And Celebrating Recent Wins

Happy Friday! Here’s a quick media roundup featuring P4ADNow leaders and patient advocates in the news this week fighting for lower drug prices

Read Article
News Feb 11, 2023

The Week in Review in Prescription Drug Pricing

For the price of a month’s supply of blood cancer drug Revlimid, you could buy two tickets to the Super Bowl AND 11 tickets to Beyoncé’s upcoming Renaissance Tour.

Read Article
Press Releases Feb 9, 2023

STATEMENT: P4ADNow Applauds Senate Judiciary Committee’s Bipartisan Passage Of Bills To Lower Drug Prices For Patients By Increasing Competition and Transparency

The following statement was issued by Merith Basey, executive director of Patients For Affordable Drugs Now, in response to the Senate Judiciary Committee’s vote to advance a package of five…

Read Article
News Feb 4, 2023

The Week in Review in Prescription Drug Pricing

AbbVie’s blockbuster drug Humira faces biosimilar competition for the first time in the drug’s 20-year reign in the United States.

Read Article
News Jan 28, 2023

The Week in Review in Prescription Drug Pricing

The drug price reforms in the Inflation Reduction Act are continuing to provide much-needed relief to patients.

Read Article
News Jan 21, 2023

The Week in Review in Prescription Drug Pricing

Happy Lunar New Year! May the year of the rabbit bring you peace, longevity, prosperity, and lower drug prices?

Read Article
News Jan 14, 2023

The Week in Review in Prescription Drug Pricing

The drug price reforms in the Inflation Reduction Act are anything but [Abbott] Elementary!

Read Article
Explainers

Drug Pricing Explained

Videos breaking down the policies, practices, and decisions that shape what Americans pay for prescription drugs.

Watch The ETHIC Act Explained: What It Means for Patients on YouTube Patient advocate featured in The ETHIC Act Explained

The ETHIC Act Explained: What It Means for Patients

1:49 · Watch on YouTube

Watch How Big Pharma Games the Patent System on YouTube Merith Basey explains how Big Pharma games the patent system

How Big Pharma Games the Patent System

3:50 · Watch on YouTube

Watch Congress Delays Negotiation. Patients Pay the Price. on YouTube Dr. Ramachandran discusses delays to Medicare drug price negotiation

Congress Delays Negotiation. Patients Pay the Price.

0:51 · Watch on YouTube

Help us spread the word

Subscribe To Our YouTube
For Press

Patients are available for interviews

Looking for a patient perspective or expert comment? We can connect you with patients, policy experts, and the latest research on prescription drug pricing.

[email protected]

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.